International Study of Biofield Therapy

Participants from 14 different countries received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners. Before and after the therapy, they reported the severity of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the effectiveness/safety of biofield therapy between countries and analyzed the factors associated with the outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Anxiety Disorders Behavior Behavioral Symptoms Depression Depression, Anxiety Dizziness Mental Disorders Neurologic Manifestations Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Participants aged 16 or older from 14 different countries (Japan, USA, Argentina, Brazil, Chile, Mexico, Peru, Taiwan, Thai, South Korea, Belgium, France, Portugal, and Spain) received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners in their country of residence. Before and after the intervention, they reported each severity level of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the improvement/exacerbation rate of a single session of biofield therapy between the countries, and examined the adjusted odds ratio of the variables associated with the changes in each category of symptoms in a real-world setting.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Individuals who agreed to receive a single session of biofield therapy for 30 minutes or longer from the volunteer investigators.
Individuals who were able to self-evaluate the change of their symptoms.
Individuals who were competent to answer the questionnaires.
Individuals who were aged 16 or older.

Exclusion criteria

no specific exclusion criteria

Treatment and study plan

Okada Purifying Therapy

Other

The practitioner raises his/her hand forward towards the recipient with the palm directed toward the recipient. The practitioner uses his/her hands alternately during the administration of Okada Purifying Therapy. The distance between the palm and the body is usually 1-2 feet, with each session typically lasting 30 to 60 minutes.

Primary outcomes

improvement/exacerbation rate of symptoms after a single session of biofield therapy

Time frame: Up to one year after all the data were collected.

The Mann-Whitney test was conducted to compare the improvement/exacerbation rates between countries.
adjusted odds ratio of the factors associated with the changes in symptoms

Time frame: Up to one year after all the data were collected.

Logistic regression analyses

Sponsors and collaborators

Lead sponsor

MOA Health Science Foundation

Other

Registry information

Official study title

International Cross-sectional Study on the Effectiveness of Biofield Therapy for the Relief of Various Symptoms

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2010
First posted: Jun 21, 2019
Registry last updated: Jun 21, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed